【摘要】 目的:探讨康复路径治疗对急性非ST段抬高性心肌梗死(NSTEMI)PCI患者的疗效及预后的影响。方法:选择在我院接受治疗的NSTEMI PCI患者120例,采用随机数表法均分为常规治疗组和康复路径组。比较两组患者的疗效以及并发症发生率;对比两组患者治疗前后焦虑自评量表(SAS)、抑郁自评量表(SDS)评分以及生活质量评分。结果:康复路径组治疗后总有效率明显高于常规治疗组(91.7%比75.0%,P=0.014)。与治疗前比较,两组患者的SAS、SDS评分均明显下降,生活质量评分均明显提高(P均=0.001);且与常规治疗组比较,康复路径组SAS[(50.3±4.8)分比(31.9±4.3)分]、SDS评分[(49.6±4.1)分比(32.7±3.8)分]降低更显著,生活质量评分[(72.9±5.8)分比(83.6±6.3)分]提高更显著(P均=0.001)。康复路径组并发症发生率明显低于常规治疗组(10.0%比26.7%,P=0.018)。结论:对非ST段抬高性心肌梗死PCI患者给予康复路径治疗,能缓解患者焦虑、抑郁情绪,改善生活质量,提高疗效,减少并发症的发生。更多还原

【Abstract】 Objective:To explore influence of rehabilitation pathway treatment on therapeutic effect and prognosis of patients with non-ST elevation myocardial infarction(NSTEMI)undergoing percutaneous coronary intervention(PCI).Methods:A total of 120 NSTEMI patients undergoing PCI treated in our hospital were selected.They were randomly and equally divided into routine treatment group and rehabilitation pathway group.Therapeutic effect,incidence of complications,scores of self-rating anxiety scale(SAS),self-rating depression scale(SDS)and quality of life(QOL)before and after treatment were observed,measured and compared between two groups.Results:After treatment,total effective rate of rehabilitation pathway group was significantly higher than that of routine treatment group(91.7% vs.75.0%,P=0.014).Compared with before treatment,after treatment,there were significant reductions in scores of SAS and SDS,and significant rise in QOL score in both groups(P=0.001 all);compared with routine treatment group after treatment,there were significant reductions in scores of SAS[(50.3±4.8)scores vs.(31.9±4.3)scores]and SDS[(49.6±4.1)scores vs.(32.7±3.8)scores],and significant rise in QOL score[(72.9±5.8)scores vs.(83.6±6.3)scores]in rehabilitation pathway group,P=0.001 all.Incidence rate of complications in rehabilitation pathway group was significantly lower than that of routine treatment group(10.0%vs.26.7%,P=0.018).Conclusion:Rehabilitation pathway treatment can alleviate emotions of anxiety and depression,improve quality of life and therapeutic effect,and reduce incidence of complications in patients with non-ST elevation myocardial infarction undergoing percutaneous coronary intervention.更多还原